CD83 and neoplasm: When analyzed on day 5 after T-cell injection, CD83 was more upregulated in the intratumoral CCR7+ CAR-T cell population than in CCR7− CAR-T cells in the tumor and T cells in the spleen (Fig. 3b, c).